FDA Efficiency Harmed By Commissioner Confirmation Process – Friedman
FDA would be more effective if the Senate were not required to confirm the commissioner post, former Acting Commissioner Michael Friedman, MD, wrote in an editorial for the Dec. 20 issue of Science
You may also be interested in...
The average total approval time for new molecular entities cleared by FDA in 2002 was 15.2 months, an analysis of new drug approvals shows
FDA Commissioner Mark McClellan, MD/PhD, is beginning his tenure at the agency by emphasizing employee morale and retention
A proposal that would allow FDA to submit its budget request directly to the congressional panels responsible for funding the agency is being explored by Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa)